⌘K

Login Start Free

Home/Filings/5/0001185185-15-000343

5//SEC Filing

Entia Biosciences, Inc. 5

Accession 0001185185-15-000343

CIK 0001408299operating

View on SEC.gov Company Profile

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 8:15 PM ET

Size

16.0 KB

Accession

0001185185-15-000343

Insider Transaction Report

Form 5

Period: 2014-12-31

Entia Biosciences, Inc.ERGO

HAUSMAN MARVIN S MD

DirectorCEO10% Owner

Transactions

Gift
Common Stock
2014-10-24$0.30/sh−30,000$9,000→ 4,157,200 total
Award
Incentive stock option
2014-09-29$0.40/sh+175,000$70,000→ 175,000 total
Exercise: $0.40From: 2015-11-01Exp: 2021-09-29→ Common Stock (175,000 underlying)
Gift
Common Stock
2014-10-25$0.30/sh−1,000$300→ 4,157,200 total
Gift
Common Stock
2014-10-25$0.30/sh−1,000$300→ 4,157,200 total
Gift
Common Stock
2014-10-24$0.30/sh−8,000$2,400→ 4,157,200 total
Gift
Common Stock
2014-10-24$0.30/sh−1,200$360→ 4,157,200 total
Gift
Common Stock
2014-10-24$0.30/sh−1,200$360→ 4,157,200 total
Gift
Common Stock
2014-10-25$0.30/sh−1,200$360→ 4,157,200 total

Footnotes (1)

[F1]These stock options vest equally over a 7 month period.

Documents

1 file

5
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Entia Biosciences, Inc.

CIK 0001408299

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001408299

Filing Metadata

Form type: 5
Filed: Feb 16, 7:00 PM ET
Accepted: Feb 17, 8:15 PM ET
Size: 16.0 KB

View on SEC.gov